OpenAlex
PricingAboutJobs
Log inGet started
Work

Duration of Dual Antiplatelet Therapy After Coronary Stenting

HTML

Year: 2016
Type: article
Source: Current Pharmaceutical Design
DOI: 10.2174/1381612822666160720144139
Authors: Gerasimos Siasos, Konstantinos Mourouzis, Evangelos Oikonomou, Manolis Vavuranakis, Georgia Vogiatzi, Alexandros Briasoulis, Nikolaos Papageorgiou, Theodore G. Papaioannou, Thodoris Zografos, Angeliki Papapanagiotou, Athanasios G. Papavassiliou, Christodoulos Stefanadis, Dimitris Tousoulis
Institutions: Brigham and Women's Hospital, Harvard University, National and Kapodistrian University of Athens, Hippocration General Hospital, Massachusetts Institute of Technology
Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: dual antiplatelet therapy, coronary stenting, P2Y12 inhibitors, aspirin, clopidogrel, prasugrel, ticagrelor, bleeding risk, thrombosis risk, drug-eluting stents, bare-metal stents, acute coronary syndrome, stable coronary artery disease, diabetes mellitus, elderly patients, individualized treatment decision-making
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2492902010
FWCI: 0.784
Cites:
Cited by: 6
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security